Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 14481–14500 of 17,529 recalls

July 11, 2014· Sandoz Inc

Recalled Item: Orphenadrine Citrate Extended Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 11, 2014· Baxter Healthcare Corp.

Recalled Item: 0.9% Sodium Chloride Injection USP

The Issue: Presence of Particulate Matter: particulate matter identified as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 11, 2014· Jubilant Cadista Pharmaceuticals Inc.

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets

The Issue: Presence of Foreign Substance: Tablets may contain dark

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 10, 2014· Hospira Inc.

Recalled Item: LACTATED RINGER'S and 5% DEXTROSE Injection USP

The Issue: Non-Sterility: Confirmed customer complaint of particulate matter floating

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 9, 2014· Gyma Laboratories Of Amer,Inc

Recalled Item: Clonidine HCL

The Issue: cGMP Deviations: GYMA laboratories Inc. has recalled multiple

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 9, 2014· Gyma Laboratories Of Amer,Inc

Recalled Item: Dipyridamole API

The Issue: cGMP Deviations: GYMA laboratories Inc. has recalled multiple

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 9, 2014· Gyma Laboratories Of Amer,Inc

Recalled Item: Propranolol HCl

The Issue: cGMP Deviations: GYMA laboratories Inc. has recalled multiple

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 9, 2014· Gyma Laboratories Of Amer,Inc

Recalled Item: Clonidine Base Micronized

The Issue: cGMP Deviations: GYMA laboratories Inc. has recalled multiple

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 8, 2014· Pfizer Inc.

Recalled Item: VIRACEPT (R) (nelfinavir mesylate) Tablets

The Issue: Labeling: Incorrect or missing lot and or Exp

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 3, 2014· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Diltiazem HCl Extended-release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 3, 2014· Fougera Pharmaceuticals Inc.

Recalled Item: Triamcinolone Acetonide Lotion USP

The Issue: Failed PH Specifications: It has been determined that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 3, 2014· Mylan Pharmaceuticals Inc.

Recalled Item: Metoprolol Succinate Extended-release Tablets

The Issue: Presence of Foreign Tablets/Capsules: A pharmacist reported a

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 3, 2014· Fougera Pharmaceuticals Inc.

Recalled Item: Triamcinolone Acetonide Lotion USP

The Issue: Failed PH Specifications: It has been determined that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 2, 2014· Bracco Diagnostic Inc

Recalled Item: E-Z-HD (barium sulfate) For Suspension (98% w/w)

The Issue: Subpotent Drug: Low out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
July 1, 2014· American Health Packaging

Recalled Item: Oxcarbazepine Tablets

The Issue: Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 1, 2014· American Health Packaging

Recalled Item: Ibuprofen Tablets

The Issue: Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
June 27, 2014· Healix Infusion Therapy, Inc.

Recalled Item: fentaNYL 5000 mcg/250 mL (20 mcg/mL) in 0.9% Sodium Chloride in a flexable bag

The Issue: Lack of Assurance of Sterility: Firm received fentanyl

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 27, 2014· Healix Infusion Therapy, Inc.

Recalled Item: fentaNYL 200 mcg/100 mL (2 mcg/mL) and Ropivacaine 0.2% in

The Issue: Lack of Assurance of Sterility: Firm received fentanyl

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 27, 2014· Hospira Inc.

Recalled Item: Fentanyl Citrate Injection

The Issue: Lack of Assurance of Sterility: Fliptop vial crimps

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 27, 2014· Healix Infusion Therapy, Inc.

Recalled Item: fentaNYL 2750 mcg/55 mL (50 mcg/mL) in prefilled syringe

The Issue: Lack of Assurance of Sterility: Firm received fentanyl

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund